Ocular Therapeutix Inc
OCUL
$9.78-2.25%
Delayed · as of Sep 24, 2026, 3:45 PM ET
Mkt cap
$1.76B
EV/Sales
19.6
P/E ratio
N/A
FY2025 Revenue
$51.95M
EPS (TTM)
$-1.40
Gross Margin (FY2025)
87.35%
Profit Margin (FY2025)
-511.90%
Beta
1.41
Div yield
N/A
Sector
Healthcare
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported OCUL revenue for 2025-12-31 was $52.0M. Net income was -$265.9M. Revenue was down 18.5% from 2024-12-31 to 2025-12-31. OCUL currently screens at market cap $1.76B.
Use this OCUL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full OCUL income, balance, and cash tables.
Ocular Therapeutix Inc (OCUL) is a biotechnology company in the Healthcare sector.
Latest cached Ocular Therapeutix Inc (OCUL) revenue for Dec 31, 2025 was $52.0M. Net income was -$265.9M. Statements: https://lician.com/financials/ocul
Ocular Therapeutix Inc (OCUL) market capitalization is $1.76B on the latest cached snapshot.
Ocular Therapeutix Inc (OCUL) cached previous close $10.00; day range $9.60 – $9.98; volume 1,270,804. Session quote: https://lician.com/quote/ocul
Ocular Therapeutix Inc (OCUL) latest cached earnings event is "OCUL earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached OCUL filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/ocul